US court invalidates Teva patent for Copaxone; Natco shares surge

June 19, 2015 8:08 AM

65 0

In a significant judgement, a US appeals court has invalidated the patent of Teva Pharmaceutical Industries on its multiple sclerosis drug, Copaxone.

``The US Court of Appeals for Federal Circuit has again found Teva’s U S Patent No. 5,800,808 (the 808 patent) for Copaxone to be invalid as indefinite,’’ the Hyderabad-based Natco Pharma said in a release issued here on Friday.

Read more

To category page